Hepatitis associated with Mycoplasma pneumoniae infection in Korean children: a prospective study

Kyu Won Kim1, Jae Jin Sung1, Hann Tchah1

  • 1Department of Pediatrics, Gachon University Gil Medical Center, Incheon, Korea.

Abstract

Insights

Mycoplasma pneumoniae (MP) infection can cause hepatitis in children, affecting 7.7% of cases. This MP-associated hepatitis typically resolves within 7.5 days with a good prognosis, warranting clinical awareness but avoiding excessive evaluation.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Hepatology

Background:

  • Mycoplasma pneumoniae (MP) is a common cause of respiratory illness in children.
  • Extrapulmonary manifestations of MP are known, but hepatitis is rarely reported.
  • Understanding MP-associated hepatitis is crucial for accurate diagnosis and management.

Purpose of the Study:

  • To investigate the clinical characteristics of hepatitis associated with Mycoplasma pneumoniae infection in pediatric patients.
  • To determine the incidence and clinical presentation of MP-associated hepatitis.
  • To assess the prognosis and outcomes of MP-associated hepatitis.

Main Methods:

  • A prospective study of 1,044 pediatric patients with MP infection was conducted.
  • Eighty patients with elevated AST/ALT levels (hepatitis) were compared to 964 without liver involvement.
  • Diagnosis was confirmed serologically for MP IgM.

Main Results:

  • Hepatitis was diagnosed in 7.7% of pediatric MP infections, predominantly in fall/winter.
  • Common symptoms included cough, fever, anorexia, and elevated AST/ALT levels.
  • Liver enzyme levels normalized within 7.5 days, with a longer hospitalization for hepatitis cases.

Conclusions:

  • MP-associated hepatitis is a recognized, albeit uncommon, complication of MP infection in children.
  • The condition generally has a favorable prognosis with prompt resolution.
  • Clinicians should consider MP hepatitis in pediatric patients but avoid unnecessary investigations.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
49
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
4.2K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.3K
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
30
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
341
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
4.0K